Improving Medical Decision Making for Older Patients With End Stage Renal Disease | MicrobiomeTrials← Back to trialsNCT04347629
Improving Medical Decision Making for Older Patients With End Stage Renal Disease
CompletedNAINTERVENTIONAL
Trial Details
Start: 2021-06-21Est. Completion: 2026-03-31
Enrollment target: 456 participants Locations- VA Palo Alto Health Care System, Palo Alto, California, United States
- Stanford University, Palo Alto, California, United States
- Brigham & Women's Hospital, Boston, Massachusetts, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Boston Medical Center, Boston, Massachusetts, United States
- Renal and Transplant Associates of New England, PC, Springfield, Massachusetts, United States
- The University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Washington, Seattle, Washington, United States
Other microbiome trials you might be interested in
Atypical Hemolytic Uremic Syndrome(aHUS)
This is a China, non-interventional, observational study and will follow the Good Phar-macoepidemiology Practices guidel…
Beijing, ChinaEst. completion Dec 31, 2027
HIVCancerChronic Granulomatous DiseaseDock 8 Deficiency
Background:
\- There are very few documents to help young adults living with advanced cancer discuss their concerns and…
Orange, United StatesCompleted Aug 16, 2023
Phase 3
Recruiting
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
This randomized phase III trial studies how well pazopanib hydrochloride works compared to placebo in treating patients …
Fairbanks, United StatesEst. completion Jul 17, 2018